| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |